178 related articles for article (PubMed ID: 23996076)
1. Progesterone decreases levels of the adhesion protein E-cadherin and promotes invasiveness of steroid receptor positive breast cancers.
Kariagina A; Xie J; Langohr IM; Opreanu RC; Basson MD; Haslam SZ
Horm Cancer; 2013 Dec; 4(6):371-80. PubMed ID: 23996076
[TBL] [Abstract][Full Text] [Related]
2. Progesterone stimulates proliferation and promotes cytoplasmic localization of the cell cycle inhibitor p27 in steroid receptor positive breast cancers.
Kariagina A; Xie J; Langohr IM; Opreanu RC; Basson MD; Haslam SZ
Horm Cancer; 2013 Dec; 4(6):381-90. PubMed ID: 23996077
[TBL] [Abstract][Full Text] [Related]
3. Role of the short isoform of the progesterone receptor in breast cancer cell invasiveness at estrogen and progesterone levels in the pre- and post-menopausal ranges.
McFall T; Patki M; Rosati R; Ratnam M
Oncotarget; 2015 Oct; 6(32):33146-64. PubMed ID: 26356672
[TBL] [Abstract][Full Text] [Related]
4. Amphiregulin mediates estrogen, progesterone, and EGFR signaling in the normal rat mammary gland and in hormone-dependent rat mammary cancers.
Kariagina A; Xie J; Leipprandt JR; Haslam SZ
Horm Cancer; 2010 Oct; 1(5):229-44. PubMed ID: 21258428
[TBL] [Abstract][Full Text] [Related]
5. Progesterone agonists and antagonists induce down- and up-regulation of estrogen receptors and estrogen inducible genes in human breast cancer cell lines.
Savoldi G; Ferrari F; Ruggeri G; Sobek L; Albertini A; Di Lorenzo D
Int J Biol Markers; 1995; 10(1):47-54. PubMed ID: 7629427
[TBL] [Abstract][Full Text] [Related]
6. Posttranslationally modified progesterone receptors direct ligand-specific expression of breast cancer stem cell-associated gene programs.
Knutson TP; Truong TH; Ma S; Brady NJ; Sullivan ME; Raj G; Schwertfeger KL; Lange CA
J Hematol Oncol; 2017 Apr; 10(1):89. PubMed ID: 28412963
[TBL] [Abstract][Full Text] [Related]
7. Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone.
Mylonas I; Makovitzky J; Jeschke U; Briese V; Friese K; Gerber B
Anticancer Res; 2005; 25(3A):1719-23. PubMed ID: 16033090
[TBL] [Abstract][Full Text] [Related]
8. Progesterone receptor A promotes invasiveness and metastasis of luminal breast cancer by suppressing regulation of critical microRNAs by estrogen.
McFall T; McKnight B; Rosati R; Kim S; Huang Y; Viola-Villegas N; Ratnam M
J Biol Chem; 2018 Jan; 293(4):1163-1177. PubMed ID: 29162724
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer.
Buxant F; Engohan-Aloghe C; Noël JC
Appl Immunohistochem Mol Morphol; 2010 May; 18(3):254-7. PubMed ID: 19875955
[TBL] [Abstract][Full Text] [Related]
10. Use of different postmenopausal hormone therapies and risk of histology- and hormone receptor-defined invasive breast cancer.
Fournier A; Fabre A; Mesrine S; Boutron-Ruault MC; Berrino F; Clavel-Chapelon F
J Clin Oncol; 2008 Mar; 26(8):1260-8. PubMed ID: 18323549
[TBL] [Abstract][Full Text] [Related]
11. Progesterone induces progesterone receptor gene (PGR) expression via rapid activation of protein kinase pathways required for cooperative estrogen receptor alpha (ER) and progesterone receptor (PR) genomic action at ER/PR target genes.
Diep CH; Ahrendt H; Lange CA
Steroids; 2016 Oct; 114():48-58. PubMed ID: 27641443
[TBL] [Abstract][Full Text] [Related]
12. Progesterone receptor regulation in T47D human breast cancer cells: analysis by density labeling of progesterone receptor synthesis and degradation and their modulation by progestin.
Nardulli AM; Katzenellenbogen BS
Endocrinology; 1988 Apr; 122(4):1532-40. PubMed ID: 3345726
[TBL] [Abstract][Full Text] [Related]
13. Challenges to defining a role for progesterone in breast cancer.
Lange CA
Steroids; 2008 Oct; 73(9-10):914-21. PubMed ID: 18243264
[TBL] [Abstract][Full Text] [Related]
14. The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast.
Villanueva H; Grimm S; Dhamne S; Rajapakshe K; Visbal A; Davis CM; Ehli EA; Hartig SM; Coarfa C; Edwards DP
J Mammary Gland Biol Neoplasia; 2018 Dec; 23(4):237-248. PubMed ID: 30338425
[TBL] [Abstract][Full Text] [Related]
15. Differential regulation of retinoblastoma protein by hormonal and antihormonal agents in T47D breast cancer cells.
Alban P; Hurd C; Dinda S; Khattree N; Moudgil VK
J Steroid Biochem Mol Biol; 2001 May; 77(2-3):135-41. PubMed ID: 11377979
[TBL] [Abstract][Full Text] [Related]
16. Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.
Li CI; Malone KE; Porter PL; Weiss NS; Tang MT; Cushing-Haugen KL; Daling JR
JAMA; 2003 Jun; 289(24):3254-63. PubMed ID: 12824206
[TBL] [Abstract][Full Text] [Related]
17. Progestin-dependent induction of vascular endothelial growth factor in human breast cancer cells: preferential regulation by progesterone receptor B.
Wu J; Richer J; Horwitz KB; Hyder SM
Cancer Res; 2004 Mar; 64(6):2238-44. PubMed ID: 15026368
[TBL] [Abstract][Full Text] [Related]
18. [Endocrinological contribution for invasion and metastasis in gynecological cancers].
Fujimoto J
Nihon Sanka Fujinka Gakkai Zasshi; 1996 Aug; 48(8):633-43. PubMed ID: 8808831
[TBL] [Abstract][Full Text] [Related]
19. Estrogen-insensitive progesterone receptors in a human breast cancer cell line: characterization of receptors and of a ligand exchange assay.
Mockus MB; Lessey BA; Bower MA; Horwitz KB
Endocrinology; 1982 May; 110(5):1564-71. PubMed ID: 7200421
[TBL] [Abstract][Full Text] [Related]
20. Wnt pathway component LEF1 mediates tumor cell invasion and is expressed in human and murine breast cancers lacking ErbB2 (her-2/neu) overexpression.
Nguyen A; Rosner A; Milovanovic T; Hope C; Planutis K; Saha B; Chaiwun B; Lin F; Imam SA; Marsh JL; Holcombe RF
Int J Oncol; 2005 Oct; 27(4):949-56. PubMed ID: 16142310
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
